Free tool
Stocks far below their 52-week high
We cover 514 companies trading at least 50% below their own 52-week high. The median market value in the group is $13.89M. Across the group, the median move over the past trading day is −0.13%. 10% of the 501 with a 200-day average trade above it. Price change over the past year runs from −92.5% to −6.1% across the middle 80 percent of the group, with a median of −60.0%.
Other lists in this group
Table
514 of 4,095 companies match these filters.Clear filters
| Ticker | Company | Price | 1M return | YTD return | 1Y return |
|---|---|---|---|---|---|
| GILD34.SA | Gilead Sciences, Inc. | 63.72 BRL | −81.50% | −81.40% | −79.11% |
| VRTX34.SA | Vertex Pharmaceuticals Incorporated | 88.56 BRL | +14.82% | −85.60% | −83.18% |
| MDTC34.SA | Medtronic plc | 59.52 BRL | +13.44% | −77.24% | −75.74% |
| M1CK34.SA | McKesson Corporation | 72.17 BRL | +2.08% | −93.69% | −92.49% |
| ESL.DE | EssilorLuxottica Société anonyme | 160.00 EUR | −2.85% | −38.15% | −39.11% |
| EL.PA | EssilorLuxottica Société anonyme | 159.15 EUR | −3.60% | −38.64% | −38.15% |
| C1IC34.SA | The Cigna Group | 59.58 BRL | −3.85% | −84.24% | −85.33% |
| B1SX34.SA | Boston Scientific Corporation | 62.21 BRL | +4.52% | −87.91% | −89.24% |
| BSX | Boston Scientific Corporation | $48.17 | +4.58% | −49.14% | −54.50% |
| BSX.DE | Boston Scientific Corporation | 42.30 EUR | +3.18% | −47.52% | −53.11% |
| A1GI34.SA | Agilent Technologies, Inc. | 72.26 BRL | +7.99% | −81.18% | −77.37% |
| ALNY | Alnylam Pharmaceuticals, Inc. | $239.00 | −17.13% | −40.28% | −47.38% |
| ZOE.DE | Zoetis Inc. | 65.74 EUR | −4.92% | −38.01% | −49.47% |
| ZTS | Zoetis Inc. | $77.52 | +0.01% | −37.91% | −49.50% |
| Z1TS34.SA | Zoetis Inc. | 24.94 BRL | +0.56% | −40.91% | −52.31% |
| A1LN34.SA | Alnylam Pharmaceuticals, Inc. | 62.25 BRL | −15.31% | −44.14% | −49.35% |
| SMMT | Summit Therapeutics Inc. | $14.23 | +13.39% | −18.78% | −42.63% |
| AFW.DE | Align Technology, Inc. | 143.00 EUR | −6.14% | +7.68% | −54.37% |
| I1QV34.SA | IQVIA Holdings Inc. | 84.64 BRL | −67.80% | −72.39% | −67.19% |
| KLRS | Kalaris Therapeutics, Inc. | $4.08 | +22.16% | −50.84% | +32.47% |
| CGTX | Cognition Therapeutics, Inc. | $1.05 | +13.64% | −28.57% | −65.69% |
| ABNX.PA | ABIONYX Pharma SA | 1.97 EUR | +5.79% | −49.58% | −31.34% |
| 4563.T | AnGes, Inc. | 38.00 JPY | −19.15% | −40.62% | −60.42% |
| PLYX | Polaryx Therapeutics, Inc. | $2.09 | +5.03% | −94.03% | −94.03% |
| ATRA | Atara Biotherapeutics, Inc. | $9.38 | +20.10% | −47.21% | −24.05% |
| ACH | Accendra Health, Inc. | $1.22 | −62.46% | −47.41% | −75.05% |
| ADOC.PA | Adocia SA | 4.01 EUR | −0.20% | −40.42% | −54.33% |
| ALDX | Aldeyra Therapeutics, Inc. | $1.56 | −1.27% | −66.60% | −73.33% |
| 4579.T | RaQualia Pharma Inc. | 568.00 JPY | +25.39% | −41.56% | +3.46% |
| PAR.AX | Paradigm Biopharmaceuticals Limited | 0.22 AUD | +30.30% | −36.76% | −24.56% |
| HYPR | Hyperfine, Inc. | $0.87 | −5.23% | −10.41% | −29.99% |
| SGMO | Sangamo Therapeutics, Inc. | $0.22 | +83.33% | −50.00% | −56.86% |
| DWTX | Dogwood Therapeutics, Inc. | $2.66 | +71.61% | −37.26% | −42.80% |
| OSE.PA | OSE Immunotherapeutics SA | 3.21 EUR | −0.19% | −39.40% | −47.94% |
| CWEB.TO | Charlotte's Web Holdings, Inc. | 0.46 CAD | +39.39% | −17.86% | +253.85% |
| EQL.ST | EQL Pharma AB (publ) | 27.05 SEK | +34.58% | −54.31% | −67.01% |
| AALR3.SA | Alliança Saúde e Participações S.A. | 2.96 BRL | −8.36% | −36.34% | −52.03% |
| CVRX | CVRx, Inc. | $3.27 | −33.94% | −53.94% | −56.75% |
| CING | Cingulate Inc. | $5.40 | +19.21% | +23.29% | +29.19% |
| GOSS | Gossamer Bio, Inc. | $0.17 | −15.17% | −93.96% | −92.93% |
| MAIA | MAIA Biotechnology, Inc. | $1.39 | +12.10% | −13.13% | −15.76% |
| VRCA | Verrica Pharmaceuticals Inc. | $4.91 | −9.07% | −40.84% | −13.25% |
| DH | Definitive Healthcare Corp. | $0.79 | +11.75% | −66.73% | −80.44% |
| RPID | Rapid Micro Biosystems, Inc. | $1.67 | −18.93% | −46.82% | −34.77% |
| CTOR | Citius Oncology, Inc. | $0.79 | +45.49% | −27.12% | −62.34% |
| GANX | Gain Therapeutics, Inc. | $1.81 | +4.62% | −43.08% | −2.69% |
| OKYO | OKYO Pharma Limited | $1.55 | −5.49% | −30.49% | −31.42% |
| AB.PA | AB Science S.A. | 0.74 EUR | +32.68% | −49.38% | −38.62% |
| 4888.T | Stella Pharma Corporation | 353.00 JPY | +18.06% | +66.51% | −11.75% |
| OM | Outset Medical, Inc. | $4.25 | −9.96% | +14.86% | −69.56% |
| TENX | Tenax Therapeutics, Inc. | $2.12 | −86.58% | −80.81% | −64.19% |
| ELTX | Elicio Therapeutics, Inc. | $2.98 | +1.02% | −62.98% | −71.29% |
| DICOT.ST | Dicot Pharma AB | 0.21 SEK | +13.89% | −32.06% | −76.06% |
| CRDF | Cardiff Oncology, Inc. | $0.98 | +20.01% | −63.00% | −54.65% |
| ANVS | Annovis Bio, Inc. | $1.78 | +5.33% | −51.23% | −24.26% |
| MDXH | MDxHealth SA | $0.76 | +83.97% | −77.96% | −84.51% |
| STX.L | Shield Therapeutics plc | 4.85 GBP | −15.65% | −50.76% | −37.42% |
| 4596.T | Kubota Pharmaceutical Holdings Co., Ltd. | 69.00 JPY | +21.05% | +64.29% | +35.29% |
| SPRO | Spero Therapeutics, Inc. | $1.22 | +2.09% | −48.09% | −38.38% |
| IBIO | iBio, Inc. | $1.43 | +2.88% | −29.21% | +76.54% |
| ZTEK | Zentek Ltd. | $0.56 | +1.82% | −16.42% | −17.65% |
| EXOZ | eXoZymes, Inc. | $7.53 | +71.02% | −31.53% | −22.42% |
| RNTX | Rein Therapeutics Inc. | $0.80 | +2.30% | −36.00% | −27.27% |
| DRIO | DarioHealth Corp. | $7.03 | −6.20% | −33.17% | −26.92% |
| NNOX | Nano-X Imaging Ltd. | $0.88 | −0.25% | −69.05% | −77.77% |
| ONCO.ST | Oncopeptides AB (publ) | 1.65 SEK | +2.93% | −66.11% | −67.92% |
| LDX.AX | Lumos Diagnostics Holdings Limited | 0.10 AUD | 0.00% | −68.75% | −25.93% |
| HYFT | MindWalk Holdings Corp. | $1.43 | +5.15% | −29.21% | −46.04% |
| SER | Serina Therapeutics, Inc. | $2.63 | +27.05% | +26.56% | −47.29% |
| MAAT.PA | MaaT Pharma SA | 3.04 EUR | +8.96% | −45.52% | −33.91% |
| HEALTH.HE | Nightingale Health Oyj | 0.93 EUR | +9.95% | −55.38% | −57.24% |
| 4570.T | Immuno-Biological Laboratories Co., Ltd. | 1,145.00 JPY | +25.69% | −41.75% | +140.06% |
| IMA | ImageneBio, Inc. | $5.43 | −5.73% | −19.67% | −60.19% |
| AHC.AX | Austco Healthcare Limited | 0.22 AUD | −1.12% | −45.68% | −37.14% |
| HRTX | Heron Therapeutics, Inc. | $0.31 | −36.29% | −75.22% | −77.04% |
| V3V.DE | FamiCord AG | 2.86 EUR | +0.70% | −52.73% | −61.35% |
| 7776.T | CellSeed Inc. | 232.00 JPY | +15.42% | −16.85% | −47.39% |
| COCH | Envoy Medical, Inc. | $0.74 | +8.39% | +5.75% | −37.09% |
| IMMP | Immutep Limited | $0.38 | −2.56% | −87.12% | −77.11% |
| ALKLH.PA | Klea Holding SA | 0.15 EUR | −4.73% | −31.24% | −32.00% |
| 4571.T | Nano Holdings, Inc. | 103.00 JPY | +8.42% | −27.46% | −31.79% |
| HEMO.L | Hemogenyx Pharmaceuticals Plc | 588.00 GBP | −8.12% | +3.52% | +70.43% |
| GNTA | Genenta Science S.p.A. | $1.13 | −28.03% | −19.86% | −70.07% |
| 000230.KS | Ildong Holdings Co., Ltd. | 6,420.00 KRW | +13.43% | −51.27% | −29.17% |
| ATYR | aTyr Pharma, Inc. | $0.55 | +11.54% | −27.40% | −89.34% |
| IMM.AX | Immutep Limited | 0.05 AUD | +8.51% | −88.14% | −79.18% |
| ALA.AX | Arovella Therapeutics Limited | 0.06 AUD | −1.59% | −33.33% | −30.34% |
| EPIS-B.ST | Episurf Medical AB (publ) | 0.08 SEK | +37.70% | +90.12% | +71.52% |
| TIL | Instil Bio, Inc. | $7.83 | +7.41% | −30.52% | −72.04% |
| BACTI-B.ST | Bactiguard Holding AB (publ) | 14.35 SEK | −8.89% | −24.47% | −46.25% |
| HYPD | Hyperion DeFi, Inc. | $3.39 | +40.08% | −5.31% | −50.87% |
| BTMD | biote Corp. | $1.55 | −30.80% | −37.25% | −53.87% |
| SOM.AX | SomnoMed Limited | 0.33 AUD | −29.79% | −57.14% | −58.23% |
| XSPRAY.ST | Xspray Pharma AB (publ) | 10.74 SEK | −35.77% | −64.61% | −76.00% |
| CANTA.ST | Cantargia AB (publ) | 1.91 SEK | +3.24% | −53.64% | −27.38% |
| TCRX | TScan Therapeutics, Inc. | $0.78 | +0.44% | −23.78% | −58.43% |
| HRTIS.HE | Herantis Pharma Oyj | 1.69 EUR | +6.42% | −26.20% | −2.31% |
| AIFORIA.HE | Aiforia Technologies Oyj | 1.17 EUR | +2.99% | −52.44% | −60.34% |
| 4263.T | SUSMED,Inc. | 469.00 JPY | −31.83% | −46.34% | −43.15% |
| COIL.L | Coiled Therapeutics plc | 9.50 GBP | −9.52% | −20.83% | −26.92% |
| ORX.ST | Orexo AB (publ) | 13.54 SEK | −5.71% | −58.27% | −35.06% |
| HOWL | Werewolf Therapeutics, Inc. | $0.99 | +120.22% | +53.30% | −25.65% |
| NSRX | Nasus Pharma Ltd. | $4.05 | +33.66% | −46.36% | −49.75% |
| MCRB | Seres Therapeutics, Inc. | $4.76 | −0.83% | −68.58% | −74.79% |
| EDSA | Edesa Biotech, Inc. | $4.94 | −0.60% | +229.33% | +105.83% |
| PHX.AX | PharmX Technologies Limited | 0.10 AUD | −5.00% | −36.67% | −17.39% |
| M7T.AX | Mach7 Technologies Limited | 0.28 AUD | −6.67% | −58.52% | −13.85% |
| CYC.AX | Cyclopharm Limited | 0.52 AUD | −13.11% | −47.51% | −48.30% |
| QTI | QT Imaging Holdings, Inc. | $3.17 | +19.62% | −46.72% | −91.44% |
| GRCE | Grace Therapeutics, Inc. | $2.15 | −4.44% | −41.26% | −29.97% |
| MGX | Metagenomi Therapeutics, Inc. | $1.22 | +0.83% | −26.95% | −34.41% |
| FLNA | Filana Therapeutics, Inc. | $0.92 | +5.05% | −55.77% | −59.98% |
| AIAI.TO | NetraMark Holdings Inc. | 0.67 CAD | −14.10% | −39.09% | −60.82% |
| XTNT | Xtant Medical Holdings, Inc. | $0.32 | −25.35% | −57.20% | −47.38% |
| ABLD.PA | ABL Diagnostics Société anonyme | 2.40 EUR | −2.44% | −37.50% | −46.67% |
| OSSD.ST | OssDsign AB (publ) | 4.00 SEK | −10.01% | −64.60% | −73.26% |
| IXHL | Incannex Healthcare Inc. | $3.70 | +25.00% | −68.38% | −81.59% |
| KPTI | Karyopharm Therapeutics Inc. Common Stock | $1.96 | −72.36% | −72.74% | −74.90% |
| MREO | Mereo BioPharma Group plc | $0.28 | −10.03% | −45.49% | −84.20% |
| ELUT | Elutia Inc. | $1.00 | +9.29% | +55.52% | −54.75% |
| MPAL.L | MedPal AI PLC | 3.75 GBP | +22.95% | −25.00% | −40.00% |
| TVGN | Tevogen Inc. | $6.70 | +19.86% | −63.19% | −85.43% |
| ALNOV.PA | Novacyt S.A. | 0.51 EUR | +16.21% | +21.19% | +7.38% |
| PAVM | PAVmed Inc. | $5.32 | −1.12% | −27.42% | −63.21% |
| VVEO3.SA | CM Hospitalar S/A | 0.67 BRL | −1.47% | −50.37% | −24.72% |
| OPTOMED.HE | Optomed Oyj | 1.71 EUR | +6.36% | −54.99% | −54.39% |
| SNWV | SANUWAVE Health, Inc. | $4.87 | −23.43% | −83.14% | −89.02% |
| NSPR | InspireMD, Inc. | $0.89 | +30.88% | −52.15% | −63.52% |
| BOT.AX | Botanix Pharmaceuticals Limited | 0.02 AUD | +5.26% | −85.19% | −86.67% |
| SHG.AX | Singular Health Group Ltd | 0.18 AUD | −12.50% | −33.96% | −46.15% |
| LGP.AX | Little Green Pharma Ltd | 0.07 AUD | −12.82% | −47.69% | −43.33% |
| CRVO | CervoMed Inc. | $2.65 | +3.52% | −65.98% | −71.78% |
| CNTX | Context Therapeutics Inc. | $0.42 | −28.31% | −72.66% | −50.73% |
| DCGO | DocGo Inc. | $0.40 | −37.37% | −55.50% | −75.60% |
| PETS | PetMed Express, Inc. | $1.79 | −10.95% | −45.76% | −43.35% |
| CPHI | China Pharma Holdings, Inc. | $0.90 | −30.84% | −25.69% | −35.78% |
| ORT-B.ST | Ortoma AB (publ) | 7.80 SEK | −13.24% | −42.22% | −66.52% |
| BDMD | Baird Medical Investment Holdings Limited | $1.18 | +10.28% | −11.94% | −52.03% |
| QLINEA.ST | Q-linea AB (publ) | 18.70 SEK | +8.41% | −35.52% | −62.97% |
| COV.AX | Cleo Diagnostics Ltd | 0.35 AUD | +12.90% | −43.09% | +4.48% |
| BCT.TO | BriaCell Therapeutics Corp. | 5.62 CAD | +15.64% | −42.77% | −46.48% |
| BCTX | BriaCell Therapeutics Corp. | $4.03 | +16.14% | −43.79% | −46.97% |
| BXT.DE | BioNxt Solutions Inc. | 0.22 EUR | +5.26% | −48.72% | −65.52% |
| 190A.T | CHORDIA THERAPEUTICS INC | 72.00 JPY | −1.37% | −35.71% | −59.32% |
| LITS | Lite Strategy, Inc. | $0.99 | +2.38% | −35.51% | −80.75% |
| ONMD | OneMedNet Corporation | $0.57 | −19.82% | −53.40% | −30.33% |
| BRETEC.HE | Bioretec Oy | 0.02 EUR | +5.77% | −96.58% | −98.25% |
| YI | 111, Inc. | $3.74 | −5.32% | +35.51% | −46.57% |
| 6557.T | AIAI Group Corporation | 785.00 JPY | +13.11% | −45.18% | −47.35% |
| 4576.T | D. Western Therapeutics Institute, Inc. | 88.00 JPY | +17.33% | −12.87% | −12.00% |
| ESLA | Estrella Immunopharma, Inc. | $0.73 | −2.54% | −47.48% | −22.34% |
| IMM.L | ImmuPharma plc | 3.41 GBP | −24.22% | −45.00% | +89.66% |
| 520A.T | J-PHARMACEUTICALS CO LTD | 280.00 JPY | +4.09% | −60.00% | −60.00% |
| ARAY | Accuray Incorporated | $0.26 | +10.12% | −68.91% | −83.17% |
| NUZ.AX | Neurizon Therapeutics Limited | 0.06 AUD | −6.67% | −31.71% | −63.87% |
| MIRA | MIRA Pharmaceuticals, Inc. | $0.75 | −10.71% | −49.66% | −45.26% |
| MDNA.TO | Medicenna Therapeutics Corp. | 0.47 CAD | +32.39% | −53.00% | −56.48% |
| ALIMP.PA | Implanet S.A. | 0.19 EUR | +13.05% | −8.35% | −2.68% |
| 4582.T | SymBio Pharmaceuticals Limited | 63.00 JPY | −4.55% | −30.00% | −57.43% |
| TELA | TELA Bio, Inc. | $0.69 | +3.15% | −39.38% | −60.73% |
| PSH0.DE | Sernova Biotherapeutics Inc | 0.08 EUR | +14.41% | −2.99% | −27.68% |
| BRNS | Barinthus Biotherapeutics plc | $0.71 | +23.93% | −3.89% | −38.04% |
| 2901.T | Wel-Dish.Incorporated | 161.00 JPY | −11.05% | −63.98% | −73.82% |
| BYSI | BeyondSpring Inc. | $0.69 | −41.77% | −57.14% | −62.09% |
| CVM | CEL-SCI Corporation | $1.61 | +34.17% | −68.74% | −87.65% |
| LTRN | Lantern Pharma Inc. | $2.18 | −16.15% | −29.90% | −46.17% |
| 4586.T | MedRx Co., Ltd | 67.00 JPY | +4.69% | −40.18% | −39.64% |
| BEAT | HeartBeam, Inc. | $0.48 | −8.65% | −80.19% | −59.20% |
| 177A.T | KOHJIN BIO CO LTD | 844.00 JPY | −4.31% | −41.14% | −51.28% |
| NXTC | NextCure, Inc. | $5.83 | +7.56% | −56.10% | +11.37% |
| EVAX | Evaxion A/S | $3.24 | +15.71% | −31.21% | +6.93% |
| MODD | Modular Medical, Inc. | $3.31 | +41.45% | −71.34% | −85.11% |
| PSTV | Plus Therapeutics Inc | $3.84 | +2.07% | −72.59% | −68.67% |
| ENLV | Enlivex Ltd. | $1.52 | −32.37% | +100.66% | +38.99% |
| DYAI | Dyadic International, Inc. | $0.66 | −37.73% | −29.78% | −29.02% |
| ATOS | Atossa Therapeutics, Inc. | $2.65 | +9.50% | −71.96% | −76.75% |
| BMT.AX | Beamtree Holdings Limited | 0.13 AUD | −3.85% | −43.18% | −48.98% |
| IMU.AX | Imugene Limited | 0.07 AUD | −17.65% | −82.05% | −75.00% |
| 7061.T | Japan Hospice Holdings Inc. | 482.00 JPY | −14.69% | −56.46% | −62.40% |
| ENL.AX | Enlitic, Inc. | 0.01 AUD | −16.67% | −72.22% | −87.50% |
| RHY.AX | Rhythm Biosciences Limited | 0.10 AUD | +23.46% | −20.00% | 0.00% |
| RENX.L | Renalytix Plc | 4.30 GBP | +62.26% | −27.12% | −26.50% |
| INTEG-B.ST | Integrum AB (publ) | 8.66 SEK | −0.92% | −16.73% | −79.55% |
| 9229.T | Sunwels Co.,Ltd. | 117.00 JPY | −5.65% | −67.04% | −84.84% |
| CLRB | Cellectar Biosciences, Inc. | $2.54 | +1.60% | −26.80% | −47.30% |
| JSPR | Jasper Therapeutics, Inc. | $0.72 | +13.43% | −60.98% | −75.24% |
| FEMY | Femasys Inc. | $2.92 | 0.00% | +358.40% | +711.11% |
| TVRD | Tvardi Therapeutics, Inc. | $1.78 | −27.05% | −56.37% | −94.18% |
| CSX.AX | CleanSpace Holdings Limited | 0.39 AUD | −4.94% | −43.38% | −52.47% |
| VHL.AX | Vitasora Health Limited | 0.01 AUD | +38.10% | −36.96% | −50.00% |
| BTAI | BioXcel Therapeutics, Inc. | $0.78 | −7.69% | −54.12% | −80.30% |
| CTSO | Cytosorbents Corporation | $0.36 | −2.70% | −45.12% | −61.29% |
| MAK.DE | Maternus-Kliniken Aktiengesellschaft | 0.92 EUR | −3.16% | −6.60% | −22.03% |
| LGVN | Longeveron Inc. | $0.70 | +17.02% | +18.60% | −14.44% |
| 4883.T | Modalis Therapeutics Corporation | 33.00 JPY | +10.00% | −43.10% | −62.07% |
| COCP | Cocrystal Pharma, Inc. | $1.12 | +20.43% | +13.13% | −27.74% |
| COSM | Cosmos Health Inc. | $0.21 | +9.64% | −58.49% | −73.37% |
| SCIB.ST | SciBase Holding AB (publ) | 20.40 SEK | −34.19% | −18.40% | −29.25% |
| NEUP | Neuphoria Therapeutics Inc. | $3.86 | +1.31% | +1.05% | −62.23% |
| XBRANE.ST | Xbrane Biopharma AB (publ) | 9.36 SEK | −6.40% | −9.77% | −72.31% |
| QNTM | Quantum BioPharma Ltd. | $3.07 | +2.33% | −56.21% | −81.67% |
| PIQ.AX | Proteomics International Laboratories Ltd | 0.17 AUD | +10.00% | −77.08% | −48.44% |
| NCEL | NewcelX Ltd. | $3.38 | −2.87% | +61.72% | −84.77% |
| CLBX.L | CelLBxHealth plc | 1.25 GBP | −1.96% | +13.64% | −79.17% |
| KTTA | Pasithea Therapeutics Corp. | $0.57 | +26.67% | −52.10% | −24.30% |
| ABVC | ABVC BioPharma, Inc. | $0.71 | −32.92% | −67.53% | −76.14% |
| NSB.AX | NeuroScientific Biopharmaceuticals Limited | 0.07 AUD | +9.84% | −33.00% | −58.12% |
| EZZ.AX | EZZ Life Science Holdings Limited | 0.56 AUD | +15.63% | −61.66% | −77.25% |
| TRJ.AX | Trajan Group Holdings Limited | 0.17 AUD | −19.05% | −75.54% | −81.82% |
| PTN | Palatin Technologies, Inc. | $10.47 | +36.33% | −34.77% | −1.23% |
| ELIC.ST | Elicera Therapeutics AB (publ) | 2.70 SEK | +13.71% | −47.97% | −61.50% |
| HKPD | Cellyan Biotechnology Co., Ltd | $0.38 | −0.68% | −53.23% | −75.96% |
| RADX | Radiopharm Theranostics Limited | $2.32 | −29.91% | −55.04% | −58.87% |
| NMTC | NeuroOne Medical Technologies Corporation | $2.00 | +19.76% | −60.88% | −55.56% |
| CALC | CalciMedica, Inc. | $0.59 | −18.18% | −91.28% | −79.74% |
| AGN.AX | Argenica Therapeutics Limited | 0.20 AUD | +30.00% | −36.07% | −69.53% |
| CYCN | Cyclerion Therapeutics, Inc. | $4.15 | +18.57% | +209.70% | +61.48% |
| PLUR | Pluri Inc. | $1.48 | −11.90% | −50.50% | −69.17% |
| 003060.KS | Aprogen Biologics Inc. | 1,878.00 KRW | −7.26% | −76.67% | −79.60% |
| TPST | Tempest Therapeutics, Inc. | $1.08 | +24.00% | −63.39% | −89.96% |
| ALZ.ST | Alzinova AB (publ) | 0.84 SEK | −13.70% | +0.48% | −39.02% |
| LPCN | Lipocine Inc. | $2.15 | +0.47% | −73.12% | −28.57% |
| AKTX | Akari Therapeutics, Plc | $9.10 | +7.95% | −21.55% | −72.42% |
| BDX.AX | BCAL Diagnostics Limited | 0.06 AUD | −17.81% | −40.00% | −6.25% |
| IIQ.AX | INOVIQ Ltd | 0.17 AUD | −12.82% | −57.50% | −58.54% |
| PLSM | Pulsenmore Ltd. | $2.71 | −17.38% | −63.18% | −63.18% |
| 4882.T | Perseus Proteomics Inc. | 149.00 JPY | +4.93% | −34.65% | −56.56% |
| MDCX | Medicus Pharma Ltd. | $0.27 | −4.11% | −83.22% | −86.77% |
| RAD.AX | Radiopharm Theranostics Limited | 0.01 AUD | −28.57% | −60.00% | −63.64% |
| DMYD-B.ST | Diamyd Medical AB (publ) | 1.03 SEK | −0.39% | −91.17% | −90.97% |
| CTXR | Citius Pharmaceuticals, Inc. | $0.58 | +15.88% | −31.95% | −57.88% |
| PBM | Psyence Biomedical Ltd. | $4.32 | +36.71% | −86.16% | −96.44% |
| PRO.ST | Promimic AB (publ) | 8.50 SEK | −18.27% | −44.98% | −41.38% |
| XINT.ST | Xintela AB (publ) | 0.18 SEK | −8.31% | −37.88% | −51.08% |
| AELIS.PA | Aelis Farma SA | 1.03 EUR | +0.39% | −11.21% | −19.22% |
| 118000.KS | METACARE CO., Ltd. | 1,297.00 KRW | +13.28% | −57.19% | −58.96% |
| 1AI.AX | Algorae Pharmaceuticals Limited | 0.01 AUD | −15.38% | −21.43% | +22.22% |
| 4881.T | FunPep Company Limited | 51.00 JPY | +2.00% | −37.04% | −55.65% |
| KALA | KALA BIO, Inc. | $0.82 | +23.65% | −97.37% | −99.83% |
| SCNX | Scienture Holdings, Inc. | $0.38 | +2.43% | −26.28% | −62.71% |
| LSTA | Lisata Therapeutics, Inc. | $1.74 | +50.00% | −11.22% | −30.40% |
| GME.DE | Geratherm Medical AG | 2.58 EUR | +1.18% | −10.42% | −16.50% |
| NRSN | NeuroSense Therapeutics Ltd. | $0.41 | −26.70% | −47.56% | −63.48% |
| APTA.L | Aptamer Group PLC | 0.38 GBP | −21.05% | −63.94% | −62.50% |
| ADVB | Advanced Biomed Inc. | $9.24 | −15.07% | +52.98% | +13.24% |
| HIND | Vyome Holdings, Inc. | $2.16 | +8.54% | −39.15% | −79.68% |
| POXEL.PA | Poxel S.A. | 0.21 EUR | +7.11% | −7.16% | −34.76% |
| INTS | Intensity Therapeutics, Inc. | $4.53 | −0.44% | −55.48% | −40.00% |
| DARE | Daré Bioscience, Inc. | $0.75 | −36.66% | −61.51% | −62.84% |
| RGNT | Regentis Biomaterials Ltd. | $2.07 | +16.29% | −69.29% | −72.40% |
| ACTI.ST | Active Biotech AB (publ) | 5.50 SEK | +6.38% | +19.57% | −62.00% |
| PASG | Passage Bio, Inc. | $4.50 | −1.53% | −61.51% | −36.08% |
| BNGO | Bionano Genomics, Inc. | $1.21 | +11.01% | −23.90% | −68.97% |
| GSS.AX | Genetic Signatures Limited | 0.09 AUD | +50.00% | −64.49% | −71.00% |
| PCK.AX | PainChek Limited | 0.09 AUD | −6.00% | −67.02% | −77.07% |
| MX1.AX | Micro-X Limited | 0.03 AUD | −7.14% | −74.00% | −66.23% |
| PHIO | Phio Pharmaceuticals Corp. | $1.20 | +18.81% | +10.09% | −40.89% |
| NICA.ST | Nanologica AB (publ) | 0.44 SEK | −3.30% | −41.33% | −69.86% |
| PTRK.ST | Physitrack PLC | 8.06 SEK | −0.49% | −38.71% | −57.58% |
| ICU | SeaStar Medical Holding Corporation | $3.12 | −9.30% | +18.63% | −63.21% |
| IZAFE-B.ST | iZafe Group AB (publ) | 0.31 SEK | 0.00% | −33.26% | −17.57% |
| 4438.T | Welby Inc. | 257.00 JPY | +5.76% | −8.87% | −23.96% |
| GTBP | GT Biopharma, Inc. | $0.29 | −8.49% | −64.49% | −74.55% |
| ALNFL.PA | NFL Biosciences SA | 0.90 EUR | +7.96% | −25.42% | −39.12% |
| TRI.AX | TrivarX Limited | 0.02 AUD | 0.00% | −20.00% | +60.00% |
| IPD.AX | ImpediMed Limited | 0.01 AUD | +25.00% | −86.11% | −87.80% |
| BOUL.ST | Boule Diagnostics AB (publ) | 3.19 SEK | −12.36% | −39.58% | −47.36% |
| ICO.ST | Iconovo AB (publ) | 1.26 SEK | +26.00% | +12.50% | −52.09% |
| HCTI | Healthcare Triangle, Inc. | $0.87 | −46.73% | −97.63% | −99.45% |
| AVCN.TO | Avicanna Inc. | 0.13 CAD | +8.33% | −40.91% | −52.73% |
| AEON | AEON Biopharma, Inc. | $0.25 | −0.98% | −77.34% | −67.34% |
| LIFE.OL | Lifecare ASA | 0.30 NOK | −11.94% | −51.51% | −97.23% |
| PDSB | PDS Biotechnology Corporation | $0.22 | −67.70% | −73.21% | −82.56% |
| IRIX | IRIDEX Corporation | $0.71 | −19.61% | −39.54% | −45.58% |
| SNTI | Senti Biosciences Holdings, Inc. | $0.39 | +1.15% | −64.87% | −75.23% |
| ALBPS.PA | Biophytis S.A. | 0.08 EUR | +422.88% | +28.41% | −50.31% |
| VIT.AX | Vitura Health Limited | 0.03 AUD | −3.85% | −59.68% | −62.69% |
| MBRX | Moleculin Biotech, Inc. | $0.60 | −72.60% | −83.43% | −96.05% |
| ASBP | Aspire Biopharma Holdings, Inc. | $8.33 | +14.98% | +52.01% | −60.93% |
| INAB | IN8bio, Inc. | $1.19 | +6.76% | −51.83% | −48.03% |
| ADGM | Adagio Medical Holdings, Inc. | $0.52 | +16.52% | −51.67% | −67.98% |
| SVNS.L | Solvonis Therapeutics plc | 0.12 GBP | −11.59% | −61.88% | −55.64% |
| VTGN | Vistagen Therapeutics, Inc. | $0.26 | +13.04% | −61.76% | −91.82% |
| TOVX | Theriva Biologics, Inc. | $0.24 | +15.81% | −6.46% | −42.10% |
| MTVA | MetaVia Inc. | $1.68 | +17.48% | −82.43% | −75.91% |
| GDTC | CytoMed Therapeutics Limited | $1.00 | +10.13% | −28.29% | −50.41% |
| AT1.AX | Atomo Diagnostics Limited | 0.02 AUD | 0.00% | −57.50% | −5.56% |
| F98.F | CytoMed Therapeutics Limited | 0.84 EUR | +12.08% | −73.06% | −50.30% |
| ALSGD.PA | SpineGuard SA | 0.10 EUR | +13.91% | +1.93% | +8.08% |
| BFRG | Bullfrog AI Holdings, Inc. | $0.57 | −2.19% | −35.09% | −54.67% |
| SINT | Sintx Technologies, Inc. | $1.58 | +1.28% | −58.20% | −58.20% |
| AZTR | Azitra, Inc. | $0.17 | +33.00% | −38.03% | −83.21% |
| QNRX | Quoin Pharmaceuticals, Ltd. | $5.18 | +23.33% | −63.21% | −29.81% |
| VIVE.ST | Vivesto AB | 8.90 SEK | +3.01% | −21.10% | −57.13% |
| ANNX.ST | Annexin Pharmaceuticals AB (publ) | 13.60 SEK | +7.09% | −31.66% | −46.03% |
| CMOTEC-B.ST | Scandinavian ChemoTech AB | 3.05 SEK | −4.69% | −33.84% | −19.74% |
| IMMNOV.ST | Immunovia AB (publ) | 0.15 SEK | −15.58% | −33.66% | −70.74% |
| AMS | American Shared Hospital Services | $1.51 | −4.43% | −28.10% | −38.62% |
| LNAI | Lunai Bioworks Inc. | $2.20 | −1.79% | −71.71% | −89.34% |
| BIBB.ST | BiBBInstruments AB | 0.59 SEK | −14.70% | −83.74% | −84.94% |
| SPAGO.ST | Spago Nanomedical AB (publ) | 0.12 SEK | +1.32% | +4.55% | −54.00% |
| EXTX.OL | EXACT Therapeutics AS | 0.75 NOK | +13.64% | −47.55% | −65.60% |
| FBLG | FibroBiologics, Inc. | $1.41 | +116.92% | −70.62% | −88.25% |
| RVPH | Reviva Pharmaceuticals Holdings, Inc. | $0.72 | −10.10% | −88.47% | −95.77% |
| 4598.T | Delta-Fly Pharma, Inc. | 104.00 JPY | +9.47% | −80.92% | −81.75% |
| CQT.AX | CONNEQT Health Limited | 0.01 AUD | −30.00% | −73.58% | −53.33% |
| CLS-B.ST | Clinical Laserthermia Systems AB (publ) | 1.86 SEK | −3.83% | −72.67% | −75.86% |
| GENI.L | GENinCode Plc | 0.90 GBP | +12.50% | −62.50% | −35.71% |
| IMRN | Immuron Limited | $1.14 | +4.11% | +43.40% | −35.77% |
| IMNN | Imunon, Inc. | $1.63 | +6.54% | −58.73% | −73.10% |
| RNV.AX | RENERVE FPO [RNV] | 0.07 AUD | −15.00% | −38.18% | −38.18% |
| XBIO | Xenetic Biosciences, Inc. | $3.86 | +54.40% | +79.53% | +35.92% |
| SKYE | Skye Bioscience, Inc. | $2.02 | +228.46% | +130.07% | −41.62% |
| WGRX | Wellgistics Health Inc | $3.03 | −14.65% | −86.04% | −96.09% |
| ACE.ST | Ascelia Pharma AB (publ) | 0.61 SEK | +16.48% | −81.26% | −88.08% |
| CODX | Co-Diagnostics, Inc. | $1.25 | −11.35% | −77.52% | −87.22% |
| 6190.T | PhoenixBio Co., Ltd. | 340.00 JPY | −2.58% | −29.17% | −15.63% |
| CIZ.L | Cizzle Biotechnology Holdings Plc | 1.50 GBP | −26.83% | −3.23% | +7.14% |
| IMC.AX | Immuron Limited | 0.04 AUD | +8.82% | +5.71% | −46.38% |
| EVGN | Evogene Ltd. | $0.54 | +10.82% | −51.95% | −58.55% |
| XWEL | XWELL, Inc. | $1.00 | −5.16% | +121.29% | −6.93% |
| SNGX | Soligenix, Inc. | $0.38 | +6.67% | −72.96% | −87.20% |
| NEWBRY.ST | Newbury Pharmaceuticals AB (publ) | 2.57 SEK | −6.55% | +110.66% | −0.39% |
| XCUR | Exicure, Inc. | $1.26 | −27.59% | −77.42% | −77.93% |
| MGRX | Mangoceuticals, Inc. | $0.37 | −32.99% | −56.32% | −80.99% |
| ENSC | Ensysce Biosciences, Inc. | $0.41 | +64.14% | −56.17% | −80.19% |
| DRMA | Dermata Therapeutics, Inc. | $1.61 | +30.36% | −26.15% | −69.57% |
| NVNO | enVVeno Medical Corporation | $11.47 | +10.27% | −6.39% | −63.76% |
| OPTI.L | OptiBiotix Health Plc | 5.65 GBP | −1.74% | −16.30% | −51.91% |
| CUPR | Cuprina Holdings (Cayman) Limited | $2.95 | −11.56% | −8.43% | −61.85% |
| ABTEC.OL | Aqua Bio Technology ASA | 4.90 NOK | +0.41% | −79.58% | −87.89% |
| ICCM | IceCure Medical Ltd | $2.29 | −17.92% | +263.49% | +132.49% |
| CELZ | Creative Medical Technology Holdings, Inc. | $1.19 | +61.60% | −39.59% | −63.27% |
| AIM | AIM ImmunoTech Inc. | $0.25 | +4.17% | −78.34% | −89.69% |
| PRM.L | Proteome Sciences plc | 1.59 GBP | −11.94% | −44.39% | −44.39% |
| AIDX | 20/20 Biolabs, Inc. | $0.56 | +22.39% | −97.64% | −97.64% |
| CANF | Can-Fite BioPharma Ltd. | $3.32 | +5.06% | −24.55% | −74.85% |
| POM | Pomdoctor Limited | $0.95 | +39.71% | +191.41% | −76.43% |
| ERMA.ST | Enorama Pharma AB (publ) | 0.89 SEK | +193.73% | −55.16% | −67.04% |
| ALOPM.PA | Oncodesign Precision Medicine Société anonyme | 0.32 EUR | +2.57% | −18.41% | −19.44% |
| CHOSA.ST | Chosa Oncology AB | 0.73 SEK | −14.15% | −20.00% | −9.00% |
| VRCI.L | Verici Dx plc | 0.23 GBP | −35.71% | −68.97% | −57.14% |
| CVB.AX | CurveBeam AI Limited | 0.02 AUD | +11.11% | −73.68% | −85.71% |
| APUS | Apimeds Pharmaceuticals US, Inc. | $4.60 | −42.50% | −72.37% | −75.66% |
| 1AD.AX | AdAlta Limited | 0.00 AUD | −25.00% | −25.00% | −25.00% |
| ACON | Aclarion, Inc. | $2.39 | +12.21% | −52.01% | −66.10% |
| SYNT.ST | SyntheticMR AB (publ) | 0.72 SEK | +24.14% | −46.07% | −74.29% |
| OBD.L | Oxford BioDynamics Plc | 0.12 GBP | −1.60% | −50.80% | −74.11% |
| INBS | Intelligent Bio Solutions Inc. | $2.26 | +41.78% | −71.36% | −85.79% |
| ITOC | iTonic Holdings Ltd. | $0.29 | +11.89% | −33.23% | −59.75% |
| JUNS | Jupiter Neurosciences, Inc. | $5.01 | +4454.55% | +396.04% | +236.24% |
| VBS.AX | Vectus Biosystems Limited | 0.17 AUD | +30.77% | +3.03% | +104.82% |
| SNOA | Sonoma Pharmaceuticals, Inc. | $1.38 | +21.05% | −62.09% | −69.80% |
| NXL | Nexalin Technology, Inc. | $0.30 | −11.94% | −49.40% | −63.35% |
| AHE.AX | Adheris Health Limited | 0.01 AUD | −22.22% | −30.00% | −75.00% |
| FRE.AX | Firebrick Pharma Limited | 0.03 AUD | +7.41% | −45.28% | −61.33% |
| NCNA | NuCana plc | $1.53 | +18.60% | −57.97% | −52.78% |
| STENO.CO | Stenocare A/S | 0.95 DKK | −1.86% | −36.11% | −22.91% |
| MODTX.ST | Modus Therapeutics Holding AB (publ) | 0.37 SEK | +0.54% | +19.35% | −85.49% |
| XTLB | XTL Biopharmaceuticals Ltd. American Depositary Shares | $2.58 | −12.84% | +7.50% | −45.34% |
| GELS | Gelteq Limited | $0.58 | −1.23% | −30.81% | −56.41% |
| AMIX | Autonomix Medical, Inc. | $6.38 | +132.00% | +1088.08% | +440.68% |
| LIMN | Liminatus Pharma, Inc. | $4.41 | +4140.38% | +587.99% | +46.03% |
| PEXA-B.ST | PExA AB (publ) | 0.34 SEK | −31.80% | +48.26% | +79.47% |
| SBX.DE | SynBiotic SE | 0.74 EUR | −32.10% | −71.02% | −76.63% |
| ACXP | Acurx Pharmaceuticals, Inc. | $1.43 | +1.42% | −48.19% | −70.64% |
| ENVB | Enveric Biosciences, Inc. | $1.37 | +3.01% | −62.67% | −92.13% |
| PCSA | Processa Pharmaceuticals, Inc. | $2.13 | −30.16% | −27.30% | −60.00% |
| KAPA | Kairos Pharma, Ltd. | $0.26 | −15.58% | −64.33% | −77.97% |
| EPN.AX | Epsilon Healthcare Limited | 0.02 AUD | −17.39% | −40.62% | −20.83% |
| NFX.L | Nuformix plc | 0.16 GBP | +6.71% | −46.10% | +80.68% |
| YCBD | cbdMD, Inc. | $0.52 | +4.02% | −55.16% | −25.17% |
| CLGN | CollPlant Biotechnologies Ltd. | $0.31 | −6.25% | −79.22% | −89.43% |
| PMCB | PharmaCyte Biotech, Inc. | $0.54 | −8.39% | −26.76% | −44.28% |
| ECS.AX | ECS Botanics Holdings Ltd | 0.01 AUD | −16.67% | −16.67% | −33.33% |
| IBX.AX | Imagion Biosystems Limited | 0.01 AUD | −16.67% | −61.54% | −37.50% |
| CDIO | Cardio Diagnostics Holdings, Inc. | $1.93 | +23.72% | −32.04% | −48.46% |
| ALPAT.PA | Plant Advanced Technologies SA | 4.20 EUR | 0.00% | −48.91% | −53.33% |
| ERNA | Ernexa Therapeutics Inc. | $4.89 | +35.46% | −83.14% | −85.93% |
| BRTX | BioRestorative Therapies, Inc. | $0.22 | −18.64% | −82.22% | −86.10% |
| BGT.AX | Bio-Gene Technology Limited | 0.02 AUD | −5.26% | −28.00% | −21.74% |
| QLIFE.ST | Qlife Holding AB (publ) | 1.81 SEK | −6.91% | −30.80% | −52.47% |
| PULM | Pulmatrix, Inc. | $1.53 | −9.23% | −32.52% | −68.62% |
| NEOLA.ST | Neola Medical AB (publ) | 0.49 SEK | −17.67% | −54.05% | −79.24% |
| PER.AX | PERCHERON FPO [PER] | 0.01 AUD | +66.67% | −47.37% | −54.55% |
| POAS | Phaos Technology Holdings (Caym | $0.17 | −21.64% | −94.54% | −95.52% |
| WOK | WORK Medical Technology Group LTD | $2.25 | +22.28% | −3.02% | −99.97% |
| LABT | Lakewood-Amedex Biotherapeutics, Inc. | $2.45 | +16.67% | −71.68% | −71.68% |
| ADXN | Addex Therapeutics Ltd | $4.23 | −28.12% | −47.71% | −46.46% |
| BIOSGN.ST | Biosergen AB (publ) | 2.48 SEK | +262.31% | −93.80% | −94.62% |
| ODI.ST | ODI Pharma AB (publ) | 2.20 SEK | −5.17% | −48.36% | +39.24% |
| CSCI.TO | COSCIENS Biopharma Inc. | 7.30 CAD | −7.59% | +151.72% | +60.79% |
| BMRA | Biomerica, Inc. | $1.69 | +5.62% | −33.21% | −46.35% |
| BCAB | BioAtla, Inc. | $3.12 | −11.61% | −88.31% | −86.04% |
| SERV.ST | Servana AB | 0.01 SEK | −16.22% | +210.00% | +106.67% |
| VVOS | Vivos Therapeutics, Inc. | $0.25 | −39.57% | −89.97% | −94.48% |
| ALPRE.PA | Predilife S.A. | 1.11 EUR | −7.50% | −64.98% | −65.74% |
| HCWB | HCW Biologics Inc. | $2.70 | +4.45% | +141.07% | −55.15% |
| ZCMD | Zhongchao Inc. | $0.81 | −31.17% | −79.16% | −89.73% |
| MLEC | Moolec Science SA | $7.18 | −1.17% | +73.43% | −63.74% |
| ELAB | PMGC Holdings Inc. | $6.05 | +539.53% | −82.25% | −96.39% |
| VNRX | VolitionRx Limited | $0.34 | −60.09% | −93.72% | −97.47% |
| SBFM | Sunshine Biopharma, Inc. | $1.24 | −13.29% | −3.13% | −16.22% |
| CVKD | Cadrenal Therapeutics, Inc. | $1.55 | −22.89% | −78.85% | −88.87% |
| JAGX | Jaguar Health, Inc. | $0.92 | −4.63% | −97.37% | −98.52% |
| TCRT | Alaunos Therapeutics, Inc. | $1.78 | −6.52% | −45.85% | −6.03% |
| SILO | Silo Pharma, Inc. | $2.50 | −43.95% | +644.05% | +290.62% |
| APVO | Aptevo Therapeutics Inc. | $2.41 | −42.76% | −74.33% | −92.52% |
| ALBLU.PA | Bluelinea Société Anonyme | 0.17 EUR | −23.18% | −65.79% | −68.11% |
| GRI | GRI Bio, Inc. | $1.91 | +33.57% | −75.64% | −95.23% |
| MBIO | Mustang Bio, Inc. | $0.56 | −11.25% | −47.66% | −63.40% |
| ACR.AX | Acrux Limited | 0.01 AUD | −9.09% | −33.33% | −33.33% |
| FEED | ENvue Medical, Inc. | $0.38 | +10.20% | −84.57% | −93.51% |
| ISPC | iSpecimen Inc. | $1.64 | −13.23% | −85.66% | −94.46% |
| OSRH | OSR Health, Inc. | $0.17 | −63.24% | −71.48% | −80.93% |
| FDBK.L | Feedback plc | 6.85 GBP | +13.22% | −36.28% | −48.30% |
| XRTX | XORTX Therapeutics Inc. | $2.22 | +8.20% | −22.18% | −43.99% |
| BIT.AX | Biotron Limited | 0.00 AUD | −20.00% | −42.86% | −50.00% |
| ADR.AX | Adherium Limited | 0.10 AUD | −4.76% | +1900.00% | +1900.00% |
| VIVS | VivoSim Labs, Inc. | $0.29 | −23.42% | −84.52% | −84.18% |
| CRIS | Curis, Inc. | $1.54 | −68.12% | +57.14% | −5.52% |
| TRP.AX | Tissue Repair Ltd | 0.09 AUD | +4.76% | −77.44% | −70.67% |
| REVB | Revelation Biosciences, Inc. | $0.96 | −8.00% | −70.63% | −91.25% |
| SXTP | 60 Degrees Pharmaceuticals, Inc. | $1.08 | −28.00% | −47.67% | −78.23% |
| RDHL | RedHill Biopharma Ltd. | $0.62 | −15.71% | −40.26% | −53.74% |
| INDCT.OL | Induct AS | 0.77 NOK | −12.47% | −83.00% | −78.07% |
| CAN.AX | Cann Group Limited | 0.00 AUD | 0.00% | −66.67% | −75.00% |
| UPC | Universe Pharmaceuticals INC | $5.32 | +66.77% | +27.88% | +44.57% |
| TNON | Tenon Medical, Inc. | $5.21 | +2642.11% | +434.91% | +297.71% |
| PMED.ST | PEPTONIC medical AB (publ) | 0.00 SEK | +20.00% | −25.00% | −25.00% |
| NXGL | NEXGEL, Inc. | $0.36 | −19.09% | −80.33% | −84.79% |
| VFX.AX | VISIONFLEX FPO [VFX] | 0.06 AUD | −5.17% | −42.11% | −56.00% |
| GCTK | GlucoTrack, Inc. | $0.32 | +7.03% | −91.72% | −92.77% |
| HIQ.AX | HITIQ Limited | 0.01 AUD | −16.67% | −76.19% | −72.22% |
| GOVX | GeoVax Labs, Inc. | $0.63 | −13.33% | −87.82% | −96.67% |
| ARTL | Artelo Biosciences, Inc. | $0.71 | −19.25% | −81.35% | −97.37% |
| GNPX | Genprex, Inc. | $3.97 | −50.56% | +121.79% | −54.10% |
| NUWE | Nuwellis, Inc. | $1.01 | −47.67% | −44.20% | −80.39% |
| EXPRS2.ST | ExpreS2ion Biotech Holding AB (publ) | 1.38 SEK | −0.36% | −91.79% | −93.99% |
| FUM.L | Futura Medical plc | 0.39 GBP | −2.26% | −68.29% | −95.67% |
| GUARD.ST | Disruptive Pharma AB (publ) | 1.47 SEK | −10.49% | +1.94% | −93.53% |
| NIVF | NewGenIvf Group Limited | $0.47 | −48.94% | −94.09% | −99.58% |
| BSFA.L | BSF Enterprise Plc | 1.15 GBP | +43.75% | −39.47% | −48.89% |
| PRFX | PRF Technologies Ltd. | $0.98 | −8.68% | −72.04% | −87.86% |
| BIAF | bioAffinity Technologies, Inc. | $5.09 | +710.51% | +317.21% | −31.59% |
| MTNB | Matinas BioPharma Holdings, Inc. | $0.20 | −32.97% | −68.32% | −90.08% |
| RGT.AX | Argent BioPharma Limited | 0.04 AUD | −36.36% | −50.00% | −74.07% |
| IVX.AX | Invion Limited | 0.04 AUD | −18.18% | −61.29% | −72.31% |
| PPBT | Purple Biotech Ltd | $1.73 | +26.28% | −73.79% | −92.21% |
| PROGEN.ST | Prostatype Genomics AB (publ) | 0.16 SEK | −4.59% | −59.48% | −79.42% |
| NOTV | Inotiv Inc | $0.01 | 0.00% | −97.94% | −99.37% |
| VAL.L | ValiRx plc | 0.16 GBP | +3.33% | −57.53% | −73.04% |
| AKAN | Akanda Corp. | $4.24 | −31.61% | −61.81% | −95.20% |
| IVF | INVO Fertility, Inc. | $1.06 | +8.16% | −76.44% | −97.38% |
| ZENI.ST | Zenicor Medical Systems AB (publ) | 0.97 SEK | +1.58% | −13.06% | −59.79% |
| ADTX | Aditxt, Inc. | $0.00 | −48.00% | −100.00% | −100.00% |
| GLH.AX | Global Health Limited | 0.06 AUD | −6.15% | −29.89% | −33.70% |
| PFSA | Profusa, Inc. | $4.26 | +309.13% | −43.27% | −86.13% |
| SPEC.ST | SpectraCure AB (publ) | 0.03 SEK | −3.33% | −79.63% | −81.77% |
| CMND | Clearmind Medicine Inc. | $1.72 | +17.81% | −91.36% | −99.58% |
| ONCO | Onconetix, Inc. | $0.64 | −22.77% | −99.20% | −99.56% |
| RNAZ | TransCode Therapeutics, Inc. | $2.34 | −53.20% | −68.38% | −76.72% |
| PPCB | Propanc Biopharma, Inc. | $1.07 | −11.57% | −92.51% | −98.54% |
| OGEN | Oragenics, Inc. | $0.53 | +6.00% | −36.90% | −51.82% |
| IBAI.L | Imaging Biometrics Ltd. | 0.64 GBP | +5.83% | −25.29% | +2.42% |
| POLAR.ST | PolarCool AB (publ) | 1.73 SEK | +8.12% | −55.87% | −67.96% |
| GABA.ST | Gabather AB (publ) | 0.03 SEK | +10.00% | +6.94% | −17.20% |
| VSD-B.ST | Vibrosense Dynamics AB (publ) | 0.70 SEK | +16.33% | −27.14% | −58.08% |
| VRAX | Virax Biolabs Group Limited | $2.77 | −4.15% | +621.35% | +365.55% |
| PHAL.ST | PharmaLundensis AB | 0.32 SEK | 0.00% | +8.19% | +37.83% |
| EXL.AX | Elixinol Wellness Limited | 0.01 AUD | 0.00% | −22.22% | −58.82% |
| ANR.AX | Anatara Lifesciences Ltd | 0.01 AUD | −10.00% | −35.71% | 0.00% |
| NX1.AX | Nexalis Therapeutics Limited | 0.01 AUD | 0.00% | −50.00% | −50.00% |
| OSX.AX | Osteopore Limited | 0.00 AUD | 0.00% | −38.46% | −60.00% |
| SLXN | Silexion Therapeutics Corp | $0.35 | −85.51% | −81.12% | −95.11% |
| DCOY | Decoy Therapeutics Inc. | $3.01 | −25.50% | −61.53% | −95.78% |
| CYP.AX | Cynata Therapeutics Limited | 0.01 AUD | −8.33% | −96.90% | −94.50% |
| MNDR | Mobile-health Network Solutions | $1.64 | −1.80% | +72.63% | −69.91% |
| SXTC | China SXT Pharmaceuticals, Inc. | $3.56 | +6037.93% | −98.64% | −98.40% |
| ATORX.ST | Alligator Bioscience AB (publ) | 0.03 SEK | −32.46% | −91.74% | −99.27% |
| IMS.ST | Invent Medic Sweden AB (publ) | 0.10 SEK | +6.95% | −69.51% | −22.48% |
| BBLG | Bone Biologics Corporation | $0.62 | −35.90% | −60.00% | −71.35% |
| BP8.AX | BPH Global Ltd | 0.00 AUD | −25.00% | −25.00% | −25.00% |
| AEMD | Aethlon Medical, Inc. | $2.28 | +307.14% | −19.15% | −85.66% |
| VSEE | VSee Health, Inc. | $0.03 | −72.64% | −93.13% | −96.63% |
| APTA.ST | Aptahem AB (publ) | 0.56 SEK | −15.96% | −51.69% | −67.65% |
| SNYR | Synergy CHC Corp. | $0.10 | −42.69% | −94.79% | −95.31% |
| MONI.ST | Monivent AB | 0.17 SEK | −5.71% | −49.39% | −37.02% |
| APLI.TO | Appili Therapeutics Inc. | 0.02 CAD | +50.00% | −40.00% | −25.00% |
| NANECH.ST | NanoEcho AB (publ) | 0.03 SEK | −3.51% | −57.96% | −72.03% |
| CHLL.L | Chill Brands Group PLC | 2.00 GBP | −9.09% | −74.19% | −87.88% |
| OAK.AX | Oakridge International Limited | 0.06 AUD | −25.00% | −20.00% | −26.83% |
| ALINT.PA | IntegraGen SA | 0.18 EUR | −18.86% | +32.22% | −36.25% |
| 2CUREX.ST | 2cureX AB (publ) | 0.66 SEK | −62.67% | +22.68% | −71.79% |
| ODIN.ST | Odinwell AB (publ) | 0.14 SEK | −25.80% | −50.71% | −61.25% |
| BDRX | Biodexa Pharmaceuticals Plc | $0.98 | −32.13% | −92.05% | −96.58% |
| PTP.DE | Pentixapharm Holding AG | 1.85 EUR | −5.61% | +20.13% | +5.47% |
| LXB.ST | Luxbright AB (publ) | 0.06 SEK | −42.86% | −88.33% | −91.76% |
| MAGLE.ST | Magle Chemoswed Holding AB (publ) | 0.40 SEK | −25.93% | −97.66% | −98.15% |
| RDGT | Ridgetech, Inc. | $1.03 | −11.21% | −99.74% | −99.43% |
Covers ~22,000 companies across the US, Europe and Asia-Pacific (ex mainland China, Hong Kong and India), refreshed nightly. Every listed stock opens as a full analysis for $9.90.